LigaSure™ Technology

Surgical Tools

Information

LigaSure™ technology has been used in more than 25 million procedures.1 Supported by a large body of evidence, our devices are what clinicians rely on and have grown to trust. Through continual improvement and innovation of our product portfolio, Medtronic’s LigaSure™ offering allows accounts to standardize vessel sealers and has led to LigaSure™ technology being the leading vessel sealing technology for more than five years in a row and counting.2 1. Based on internal sales data from FY01-FY20. October 2019. 2. Based on radiofrequency and ultrasonic market share (revenue-based) data, generated from IMS market reports: 1999-CY2017. Data on file at Medtronic.

URL

https://www.medtronic.com/covidien/en-us/products/vessel-sealing.html

MedtronicAt Medtronic (www.medtronic.com), we're committed to innovating for life by pushing the boundaries of medical technology and changing the way the world treats chronic disease. To do that, we're thinking beyond products and beyond the status quo - to continually find more ways to help people live better, longer. †When compared to manual counting only. 1. Williams TL, Tung DK, Steelman VM, Chang PK, Szekendi MK, Retained Surgical Sponges: Findings from Incident Reports and a Cost-Benefit Analysis of Radiofrequency Technology, Journal of the American College of Surgeons, 2014, doi: 10.1016/j.jamcollsurg.2014.03.052